+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Diabetes Management Market by type, Product: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • PDF Icon

    Report

  • 169 Pages
  • March 2020
  • Region: Global
  • Allied Market Research
  • ID: 5031466

The global digital diabetes management market was valued at $3,375.8 million in 2018 and is projected to reach $17,118.7 million by 2026, registering a CAGR of 22.5% from 2019 to 2026. Diabetes is one of the most prevalent chronic diseases that occurs due to the malfunctioning of the pancreas. The condition arises when the pancreas does not produce enough insulin, or the body is unable to effectively utilize the insulin that has been produced. As per the data published by WHO, in 2018, the number of people suffering from diabetes has significantly risen from 108 million in 1980 to approximately 422 million in 2014. The prevalence of diabetes across the globe has increased from 4.7% to 8.5%. In 2016, around 1.6 million deaths occurred due to diabetes. Thus, it is essential to manage diabetes in order to maintain blood sugar levels in the human body.





Diabetes management includes measuring & recording blood sugar levels, measuring carbohydrate intake, along with tracking exercises and day-to-day activities. Thus, tracking these activities digitally offers continuous patient monitoring allowing the patients as well as physicians to better diagnose the current condition and suggest medications accordingly.

Prominent players in the market have adopted various strategies such as partnerships, product approvals and product launching for maintaining their share in global digital diabetes management thereby addressing the evolving healthcare needs amongst the patients and healthcare providers.

The major factors driving the growth of the market are the increase in the adoption of smartphones & tablets coupled with healthcare apps and surge in the diabetic population globally. In contrast to these, the market growth is hampered by a lack of awareness regarding digital diabetes management in developing countries and patient data privacy concerns. On the contrary, emerging markets offer significant opportunities for the growth of the global digital diabetes management market.

The global digital diabetes management market is segmented based on type, product and region. Based on type, the market is categorized into Handheld Devices and Wearable Devices. Based on the product, the digital diabetes management market divided into Continuous blood glucose monitoring systems, Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens and Apps. Based on the region, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS


  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019-2026, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global clinical nutrition market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Type


  • Handheld Devices
  • Wearable Devices

By Product


  • Continuous blood glucose monitoring systems
  • Smart Glucose Meter
  • Smart Insulin Pumps
  • Smart Insulin Pens
  • Apps

By Region


  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Spain
  • Italy
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • India
  • China
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS


  • Abbott laboratories
  • ACON Laboratories, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Dexcom, Inc
  • F. Hoffmann-La Roche Ltd.
  • Johnson and Johnson, Medtronic Plc
  • Novo Nordisk A/S
  • Terumo corporation
Frequently Asked Questions about the Global Digital Diabetes Management Market

What is the estimated value of the Global Digital Diabetes Management Market?

The Global Digital Diabetes Management Market was estimated to be valued at $3375.8 million in 2018.

What is the growth rate of the Global Digital Diabetes Management Market?

The growth rate of the Global Digital Diabetes Management Market is 22.5%, with an estimated value of $17118.7 million by 2026.

What is the forecasted size of the Global Digital Diabetes Management Market?

The Global Digital Diabetes Management Market is estimated to be worth $17118.7 million by 2026.

Who are the key companies in the Global Digital Diabetes Management Market?

Key companies in the Global Digital Diabetes Management Market include Abbott laboratories, ACON Laboratories Inc., Bayer AG, Becton, Dickinson, Company, Dexcom Inc, F. Hoffmann, La Roche Ltd. and Medtronic Plc.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in adoption of smartphones & tablets integrated with healthcare apps
3.3.1.2. Surge in diabetic population globally
3.3.2. Restraint
3.3.2.1. Lack of awareness regarding digital diabetes management in developing countries
3.3.2.2. Patient data privacy concerns
3.3.3. Opportunity
3.3.3.1. High growth potential offered by emerging markets
CHAPTER 4: DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Handheld devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market analysis, by region
4.2.3. Market analysis, by country
4.3. Wearable devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market analysis, by region
4.3.3. Market analysis, by country
CHAPTER 5: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Continuous blood glucose monitoring systems
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Smart glucose meter
5.3.1. Market analysis, by region
5.3.2. Market analysis, by country
5.4. Smart insulin pumps
5.4.1. Market analysis, by region
5.4.2. Market analysis, by country
5.5. Smart insulin pens
5.5.1. Market analysis, by region
5.5.2. Market analysis, by country
5.6. Apps
5.6.1. Market analysis, by region
5.6.2. Market analysis, by country
CHAPTER 6: DIGITAL DIABETES MANAGEMENT MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast, by country
6.2.3. Market size and forecast, by type
6.2.4. Market size and forecast, by product
6.2.5.1. U. S. market size and forecast, by type
6.2.5.2. U. S. market size and forecast, by product
6.2.5.3. Canada market size and forecast, By type
6.2.5.4. Canada market size and forecast, by product
6.2.5.5. Mexico market size and forecast, By type
6.2.5.6. Mexico market size and forecast, by product
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast, by country
6.3.3. Market size and forecast, by type
6.3.4. Market size and forecast, by product
6.3.4.1. Germany market size and forecast, by type
6.3.4.2. Germany market size and forecast, by product
6.3.4.3. France market size and forecast, by type
6.3.4.4. France market size and forecast, by product
6.3.4.5. UK market size and forecast, by type
6.3.4.6. UK market size and forecast, by product
6.3.4.7. Italy market size and forecast, by type
6.3.4.8. Italy market size and forecast, by product
6.3.4.9. Rest of Europe market size and forecast, by type
6.3.4.10. Rest of Europe market size and forecast, by product
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
6.4.3. Market size and forecast, by type
6.4.4. Market size and forecast, by product
6.4.4.1. Japan market size and forecast, by type
6.4.4.2. Japan market size and forecast, by product
6.4.4.3. China market size and forecast, by type
6.4.4.4. China market size and forecast, by product
6.4.4.5. India market size and forecast, by type
6.4.4.6. India market size and forecast, by product
6.4.4.7. Australia market size and forecast, by type
6.4.4.8. Australia market size and forecast, by product
6.4.4.9. Rest of Asia-Pacific market size and forecast, by type
6.4.4.10. Rest of Asia-Pacific market size and forecast, by product
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
6.5.3. Market size and forecast, by type
6.5.4. Market size and forecast, by product
6.5.4.1. Brazil market size and forecast, by type
6.5.4.2. Brazil market size and forecast, by product
6.5.4.3. Saudi Arabia market size and forecast, by type
6.5.4.4. Saudi Arabia market size and forecast, by product
6.5.4.5. South Africa market size and forecast, by type
6.5.4.6. South Africa market size and forecast, by product
6.5.4.7. Rest of LAMEA market size and forecast, by type
6.5.4.8. Rest of LAMEA market size and forecast, by product
CHAPTER 7: COMPANY PROFILES
7.1. Abbott laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. ACON LABORATORIES, INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments
7.3. Bayer AG.
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Product portfolio
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.4. BECTON, DICKINSON AND COMPANY
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. DEXCOM, INC
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. F. HOFFMANN-LA ROCHE LTD.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Johnson and Johnson
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Medtronic Plc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. NOVO NORDISK A/S
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Terumo corporation.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance

Executive Summary

According to this report titled, 'Digital Diabetes Management Market by Type, Product and Region: Global Opportunity Analysis and Industry Forecast, 2019-2026' the global digital diabetes management market was valued at $3.3million in 2018 and is projected to reach $17.1 billion by 2026, registering a CAGR of 22.5% from 2019 to 2026.

Digital diabetes management allows patients as well as healthcare professionals to analyze and monitor the blood glucose level on day-to-day basis. These devices help patients in deciding their regular food intake and insulin dosages. Thus, advancements in smartphones including augmented & virtual reality has helped patients to better manage their diabetic conditions and provide solutions before affecting the life of the patient severely.

Increase in adoption of smartphones integrated with healthcare applications and a rise in diabetic population are some of the factors responsible for propelling the market growth in coming years. However, data privacy concerns among the users and lack of awareness regarding the digital apps for monitoring diabetes in the developing countries are expected to hinder the market growth. On the contrary, emerging markets are supposed to provide newer opportunities for the growth of global digital diabetes management market.

The global digital diabetes management market is segmented based on type, product and region. Based on type, the market is categorized into h and held devices and wearable devices. The wearable devices segment is anticipated to grow in the forecast period owing to the advantages it offers such as behavioral interventions to people at their place, better accessibility, scalability, and the ability to test anywhere. Based on product, the digital diabetes management market divided into continuous blood glucose monitoring systems, smart glucose meter, smart insulin pumps, smart insulin pens and apps. The Continuous blood glucose monitoring systems segment is likely to grow in coming future owing to the provision in the devices such as real time values of the glucose levels and alerts to the patient in the event of hypo or hyperglycemia.

Based on region, the market is further analyzed across North America, Europe, Asia-Pacific and LAMEA. North America holds a dominant share in the global digital diabetes management market due to increasing awareness regarding digital health and large number of patients suffering from chronic illness. Moreover, factors such as well-developed supply-side infrastructure, rapid acceptance of innovative technologies, and adequate reimbursements are further driving the market growth.

According to Onkar Sumant, Manager, Healthcare, “Rising adoption of smartphones integrated with healthcare applications and surge in diabetic population are some of the factors responsible for propelling the market growth in coming years. On the contrary, data privacy concerns among the users is one of the major hindrancesfor the growth of the market.”

The report provides a comprehensive analysis of the key players operating in the global digital
diabetes management market, which include Abbott laboratories, ACON Laboratories, Inc., Bayer AG, Becton, Dickinson and Company, Dexcom, Inc, F. Hoffmann-La Roche Ltd., Johnson and Johnson, Medtronic Plc, Novo Nordisk A/S, and Terumo corporation. The other players in the value chain (companies not included in the report) include Insulet Corporation, Tandem Diabetes Care, Ascensia Diabetes Care, and LifeScan.

KEY FINDINGS OF THE STUDY
  • By type, the wearable devices segment occupied 55.45% share of the global digital diabetes management market in 2018.
  • By product, application “App’s” segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • North America accounted for approximately 40.0% of the global digital diabetes management market share in 2018.

Companies Mentioned

  • Abbott laboratories
  • ACON Laboratories Inc.
  • Bayer AG
  • Becton
  • Dickinson, Company
  • Dexcom Inc
  • F. Hoffmann-La Roche Ltd.
  • Johnson, Johnson
  • Medtronic Plc
  • Novo Nordisk A/S
  • Terumo corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...